Barnes & Noble Education Reports Third Quarter Fiscal Year 2024 Financial Results
Retail Segment Gross Comparable Store Sales Increased 8.8% First Day® Complete Revenue Increased to $110 Million from $67 Million Consolidated GAAP Net Loss from... Read more.
Granite Declares Quarterly Dividend
WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite Construction Incorporated (NYSE: GVA) today announced that its Board of Directors has declared a quarterly... Read more.
Granite Declares Quarterly Dividend
WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite Construction Incorporated (NYSE: GVA) today announced that its Board of Directors has declared a quarterly... Read more.
AHF Thanks Matsui for Fighting Big PhRMA
340B PATIENTS Act would stop drug companies from restricting where patients can fill prescriptions WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation... Read more.
CUMMINS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Cummins Inc. – CMI
NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti,... Read more.
EQUITRANS MIDSTREAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Equitrans Midstream Corporation – ETRN
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”)... Read more.
L.S. STARRETT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of The L.S. Starrett Company (NYSE: SCX)
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”)... Read more.
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast
RICHMOND, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled... Read more.
Ventas Declares First Quarter 2024 Dividend of $0.45 Per Common Share
CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly... Read more.
MINM Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Minim, Inc. is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Minim, Inc. (NASDAQ: MINM) and e2Companies,... Read more.